Rankings
▼
Calendar
TRDA Q3 2020 Earnings — Entrada Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
TRDA
Entrada Therapeutics, Inc.
$518M
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$7M
Net Income
-$7M
EPS (Diluted)
$-0.34
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$75,000
← FY 2020
All Quarters
Q4 2020 →